From: Longitudinal transcriptional analysis of peripheral blood leukocytes in COVID-19 convalescent donors
Single | Double | Three | Four | Five | P Value | |
---|---|---|---|---|---|---|
Number | 93 | 46 | 12 | 6 | 5 | |
Age (years) | 46.77 ± 15.32 | 48.5 ± 15.32 | 54.47 ± 14.03 | 47.5 ± 15.82 | 55.68 ± 6.65 | 0.0143 |
Sex (n, %) | ||||||
Male | 46 (49.4) | 18 (40.4) | 5 (46.1) | 2 (33.3) | 4 (75) | |
Female | 47 (50.5) | 28 (59.5) | 7 (53.8) | 4 (66.6) | 1 (25) | |
Ethnicity (n, %) | ||||||
Caucasian | 75 (80.6) | 31 (68.0) | 10 (84.6) | 2 (33.3) | 4 (75) | |
African American | 9 (9.6) | 4 (8.5) | ||||
Asian | 3 (3.2) | 7 (14.8) | 1 (16.6) | |||
Hispanic | 1 (1.07) | 2 (4.2) | 2 (18.1) | 1 (16.6) | 1 (25) | |
Mixed | 2 (2.1) | 1 (2.1) | 1 (16.6) | |||
Others | 1 (2.12) | 1 (16.6) | ||||
Declined | 2 (2.1) | |||||
Unknown | 1 (1.0) | |||||
BMI | 27.53 ± 5.91 | 27.39 ± 6.283 | 25.12 ± 3.46 | 27.24 ± 3.93 | 33.86 ± 8.16 | < 0.0001 |
Severity (n, %) | ||||||
Mild | 87 (93.5) | 44 (95.7) | 9 (76.9) | 5 (83.3) | 3 (50) | |
Moderate | 5 (5.3) | 1 (2.1) | 2 (15.3) | 1 (16.6) | 1 (25) | |
Severe | 1 (1.0) | 1 (7.6) | 1 (25) | |||
Asymptomatic | 1 (2.12) | |||||
Anti-SARS-Cov2 | ||||||
Total Anti-SARS-CoV-2 | 291.9 ± 262.4 | 403.5 ± 288 | 544.4 ± 299.4 | 372.5 ± 330.6 | 527.4 ± 321.4 | < 0.0001 |
IgG Anti-SARS-CoV-2 | 8.148 ± 6.517 | 10.42 ± 7.574 | 14.31 ± 8.038 | 10.3 ± 8.265 | 15.92 ± 6.792 | < 0.0001 |
Median Neutralizing Abs | 1:40 | 1:80 | 1:80 | 1:80 | 1:80 |